LSA
NGNE icon

Leonteq Securities AG’s Neurogene NGNE Stock Holding History

Leonteq Securities AG’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,000
Closed -$20.6K – 1425
2025
Q4 		$20.6K Hold
1,000
– – ﹤0.01% 1090
2025
Q3 		$17.3K Hold
1,000
– – ﹤0.01% 1056
2025
Q2 		$14.9K Sell
1,000
-1,000
-50% -$15.7K ﹤0.01% 1020
2025
Q1 		$23.5K Hold
2,000
– – ﹤0.01% 961
2024
Q4 		$45.7K Buy
+2,000
New +$74.4K ﹤0.01% 841

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Leonteq Securities AG's NGNE Position: Q1 2026 in Review

Leonteq Securities AG sold out of Neurogene (NGNE) in Q1 2026, closing a stake of 1,000 shares — an estimated $20.6K sold.

Leonteq Securities AG first reported a position in NGNE in Q4 2024 and held it in 5 quarters. The position peaked at $45.7K in Q4 2024. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Leonteq Securities AG reported no remaining Neurogene position as of Q1 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 1,000 Neurogene shares in Q1 2026, an estimated $20.6K.
  • Leonteq Securities AG first reported a position in Neurogene in Q4 2024 and held it in 5 quarters.
  • Leonteq Securities AG's Neurogene position peaked at $45.7K in Q4 2024.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Leonteq Securities AG's 13F filing for Q1 2026, filed 27 Apr 2026.